Pharmaceutical Technology

News, views and contacts from the global Pharmaceutical industry
14 September 2018
WEEKLY UPDATE
Digital Magazine
Latest Companies

Zenatek

PolyPeptide Group

Peptide Specialty Laboratories

Bioassay

Kingfisher International

Pharmaceutical Technology on Facebook

Join Pharmaceutical Technology on Facebook!
We're on Facebook and we'd like you to join us there too. Now there's a new way to keep up on our biggest stories, breaking news and exclusive content. Become a fan of Pharmaceutical Technology on Facebook and click the 'like' button. Simple as that!

White Papers

Polpharma Finished Dosage Formulation Dossier – Under Development
This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development. 

Dividella Brochure
In the packaging business, time-to-market is critical. A new product has to be able to be packaged without losing any time and it must be possible to respond within a very short time to marketing or customer requirements.

Portable Transmission Raman Spectroscopy
Content uniformity (CU) testing is a crucial task in pharmaceutical manufacturing, as it ensures that each product that reaches a consumer contains a safe dosage of the active pharmaceutical ingredient (API).

Flexible Drug Containers for Parenteral Drugs
Self-medication is becoming more popular, driven by cost considerations. Valuable time of healthcare personnel and the high cost of hospital stays are outweighing the costs of treatment drastically.

Leachables and Extractables in Pharmaceuticals
Extractables are organic and inorganic chemical entities that can be released from a test article and into an extraction solvent under laboratory conditions.

Press Releases

Pharma 4.0 and Enabling the Factory of the Future
The terms Internet of Things (IoT) and Industry 4.0 reference technology-driven initiatives that have begun to disrupt traditional manufacturing methods, equipment and processes.

Italian Pharmaceutical Company Selects Emerson to Enable Digital Transformation
Pharmaceutical ingredients manufacturer Fabbrica Italiana Sintetici (FIS) has selected Emerson to digitise operations and work processes at three manufacturing sites in Italy.

Gerresheimer and Sensile Medical to Attend CPhI Worldwide Together
By acquiring Switzerland-based Sensile Medical in July this year, Gerresheimer is expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities.

Malvern Panalytical Announces Next Batch of Seminars
Malvern has announced a series of seminars taking place throughout September and October. If you are interested in attending any of the events and have any questions, please make an enquiry using the form on this page.

Röchling Acquires American Medical Technology Specialist
Röchling Advent Tool & Mold has acquired the American medical technology specialist Precision Medical Products (PMP) based in Denver, Pennsylvania, US.

Features

Syphilis will remain a global burden in the next decade
Syphilis continues to be a global disease burden with a high and growing number of new cases each year.

Concert Pharma’s Phase IIa alopecia areata study may lack cosmetic relevance
Concert Pharmaceuticals’ CTP-543 (deuterated-modified ruxolitinib) could have cosmetically insignificant results in its Phase IIa alopecia areata (AA) study, despite the expectation that it will reach a statistically and clinically significant difference from placebo on the primary endpoint (outcome measure).

NICE rejects NHS use of Roche’s Ocrevus for PPMS
In its final draft guidance, the UK’s pricing regulator the National Institute of Health and Care Excellence (NICE) has not recommended Roche’s Ocrevus (ocrelizumab) for routine National Health Service (NHS) use to treat primary progressive multiple sclerosis (PPMS).

Blood Cancer Awareness Month: revolutionary treatments in the pipeline
In 2010, US Congress designated September as Blood Cancer Awareness Month. It is frequent for some patients to not respond well to the current standard of care: biologics and chemotherapy; what are the current major new, innovative therapeutic approaches being developed for this common form of cancer?

CAR-T approved in Europe but NICE verdict is divided: what happens next?
Chimeric antigen receptor T-cell (CAR-T) therapy reached its next major milestone on August 27 2018, when the EMA approved Novartis’ Kymriah (tisagenlecleucel) in refractory/relapsed (R/R) B-cell acute lymphoblastic leukemia (ALL) and R/R diffuse large B-cell lymphoma (DLBCL), and also recommended approval for Gilead’s Yescarta (axicabtagene ciloleucel) in R/R DLBCL and R/R primary mediastinal large B-cell lymphoma (PMBCL).

Projects

BeiGene Biologics Manufacturing Facility, Guangzhou
BeiGene Biologics is developing a new biologics manufacturing facility in Guangzhou in the Guangdong province of China.

Sanofi’s Vaccine Manufacturing Facility, Toronto, Ontario, Canada
French pharmaceutical company Sanofi Pasteur has unveiled plans to build a new vaccine manufacturing facility in Toronto, Ontario, Canada.

WuXi Biologics’ Biologics Production Facility, Massachusetts, US
In June 2018, Chinese biopharmaceutical company WuXi Biologics announced the development of a new production facility in Worcester, Massachusetts, US.

Biogen’s Biologics Manufacturing Facility, Solothurn, Switzerland
Biogen’s new biologics manufacturing facility is being developed in Luterbach near Solothurn, Switzerland.

Pfizer’s Sterile Injectable Production Facility, Michigan
In June 2018, Pfizer announced plans to build a sterile injectables production facility at Portage in Kalamazoo County, Michigan, US.

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.pharmaceutical-technology.com is a product of Kable.
Copyright
2018 Kable, a trading division of Kable Intelligence Limited.